European Primary Care Cardiovascular Society

New ACC/AHA Hypertension Practice Guidelines stress lifestyle improvement and lower SBP target

Nov. 14, 2017 - news

AHA 2017 The new guidelines now define hypertension as >130/80 mmHg, emphasize the need for lifestyle changes and specify details of accurate BP measurement methods. 

In the SPRINT trial, presence or absence of staff did not affect observed CVD risk reduction

Nov. 14, 2017 - news

AHA 2017 A post-hoc survey of the SPRINT examined whether the presence or absence of physician or nursing in the BP measurement changed the treatment effect.

Hypertension in midlife associated with higher risk of dementia in women

Oct. 18, 2017 - Gilsanz P et al., Neurology 2017

Although midlife hypertension is more common in men, it was only associated with the risk of dementia in women, suggesting that hypertension is a modifiable risk factor for dementia in women.

Diabetic patients at high CV risk benefit from intensive BP control

Oct. 5, 2017 - Buckley LF et al., Diabetes Care 2017

In a SPRINT-eligible ACCORD-BP population, a high-risk cohort of diabetic patients, intensive BP control at a goal of <120 mmHg, reduced CVD outcomes.

Obesity without metabolic abnormalities still associated with increased CV risk

Sep. 25, 2017 - Caleyachetty R et al., J Am Coll Cardiol 2017

Individuals previously considered “metabolically healthy obese” are still at higher CV risk compared with normal weight metabolically healthy persons, according to a large UK health record dataset.

In patients with very high BP, intensive blood pressure lowering can be harmful

Sep. 9, 2017 - news

ESC 2017 Posthoc SPRINT analysis shows that persons with SBP ≥160 mmHg and low Framingham risk score, have a higher risk of all-cause mortality with intensive treatment.

To estimate an individual’s sodium intake, a single 24-hour urine collection does not suffice

July 18, 2017 - Olde Engberink RHG et al., Circulation. 2017

Multiple 24-hour urine collections are needed for reliable estimation of individual sodium intake and the associated CV and renal risk.

Improved hypertension control with quarter-dose combinations of BP-lowering agents

July 17, 2017 - Bennett A, et al. - Hypertension. 2017

In a meta-analysis, dual quarter-dose combinations of BP-lowering agents were as effective as standard-dose monotherapy, whereas a quadruple quarter-dose combination was twice as efficacious. 

CV risk factors early in life associated with worse midlife cognitive performance

June 21, 2017 - Rovio SP et al, JACC 2017

In a population-based cohort, the cumulative burden of BP, serum total- and LDL-C, and smoking from childhood and adolescence, were independently associated with worse midlife cognitive performance.

Certain traditional Chinese medicines may help improve CV risk or even CVD

June 14, 2017 - Hao P et al., JACC 2017

Systematic review of RCT evidence suggests that some TCM medications might improve CV risk factors and some may exert beneficial effects on ASCVD and chronic HF. Not all studies are of high methodological quality.

Meta-analyses confirms CVD and all-cause mortality benefit of intensive SBP reduction

June 7, 2017 - Bundy JD et al., JAMA Cardiol. 2017

A large meta-analysis demonstrated that treating patients to reduce SBP below currently recommended targets was associated with a significantly reduced risk of CVD and all-cause mortality.

Stroke subtypes show different risk factors that depend on age

May 13, 2017 - Hauer AJ et al., JAHA 2017

Various stroke subtypes have different risk profiles particularly in younger individuals, supporting a more tailored primary and secondary stroke prevention strategy in younger patients.